Manasi P Jogalekar
5PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy
|Jul 27, 2022
COVID-19 and diabetes: What do we know so far?Prakash Gangadaran, Himabindu Padinjarathil, Shri Hari Subhashri Rajendran
|May 13, 2022
Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery.Anand Krishnan, Prakash Gangadaran, Vivek P Chavda
|May 24, 2021
SARS-CoV-2 variants: A double-edged sword?Manasi P Jogalekar, Anurag Veerabathini, Prakash Gangadaran
|Mar 24, 2021
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development.Manasi P Jogalekar, Anurag Veerabathini, Ankit B Patel
Pageof 1
Frequent Collaborators
3 joint publications
Prakash Gangadaran
2 joint publications
Prasanna Ramani
2 joint publications
James S Fraser
2 joint publications
Alan Ashworth
2 joint publications
Adam R Renslo
2 joint publications
Melanie Ott
1 joint publications
Byeong-Cheol Ahn
1 joint publications
Priyadarshini Jaishankar
1 joint publications
Galen J Correy
1 joint publications
Patrick C O'Leary
